ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

CRIS Curis Inc

14.47
-0.05 (-0.34%)
27 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Curis Inc CRIS NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
-0.05 -0.34% 14.47 14:00:04
Open Price Low Price High Price Close Price Previous Close
14.44 14.25 14.6899 14.47 14.52
more quote information »

Recent News

Date Time Source Heading
05/4/202422:30PRNUSCuris Reports Inducement Grants Under NASDAQ Listing Rule..
04/4/202422:30PRNUSCuris to Present at Upcoming Healthcare Conferences in April
13/2/202408:16EDGAR2Form SC 13G - Statement of acquisition of beneficial..
09/2/202408:36EDGAR2Form S-8 - Securities to be offered to employees in employee..
09/2/202408:27EDGAR2Form S-3 - Registration statement under Securities Act of..
09/2/202408:01EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
09/2/202400:01EDGAR2Form 8-K - Current report
09/2/202400:00PRNUSCuris Provides Fourth Quarter 2023 Business Update
02/2/202400:00PRNUSCuris to Release Fourth Quarter 2023 Financial Results and..
12/1/202400:13EDGAR2Form 8-K - Current report
06/1/202400:00PRNUSCuris Reports Inducement Grants Under NASDAQ Listing Rule..
22/12/202308:00EDGAR2Form 10-K/A - Annual report [Section 13 and 15(d), not S-K..
13/12/202300:00PRNUSCuris Announces Initial Combination Study Data from its..
12/12/202300:00PRNUSCuris Presented Clinical Data from the TakeAim Leukemia..
07/12/202300:00PRNUSCuris Announces Three Presentations at ASH
06/12/202300:00PRNUSCuris Enters into Agreement for Emavusertib / Pembrolizumab..
02/11/202323:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02/11/202323:01EDGAR2Form 8-K - Current report
02/11/202323:00PRNUSCuris Provides Third Quarter 2023 Business Update
26/10/202323:30PRNUSCuris to Release Third Quarter 2023 Financial Results and..
06/10/202323:56PRNUSCuris Reports Inducement Grants Under NASDAQ Listing Rule..
29/9/202306:05EDGAR2Form 8-K/A - Current report: [Amend]
28/9/202322:54EDGAR2Form 8-K - Current report
12/9/202322:00PRNUSCuris Announces Date for the 2nd Symposium on IRAK4 in..
06/9/202322:13PRNUSCuris to Present at Upcoming Healthcare Conferences in..
19/8/202306:02EDGAR2Form DEF 14A - Other definitive proxy statements
05/8/202306:09EDGAR2Form PRE 14A - Other preliminary proxy statements
04/8/202306:04EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
04/8/202306:02EDGAR2Form 8-K - Current report
04/8/202306:01PRNUSCuris Provides Second Quarter 2023 Business Update
28/7/202308:25PRNUSCuris to Release Second Quarter 2023 Financial Results and..
07/7/202306:30EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
06/7/202323:28EDGAR2Form 8-K - Current report
06/7/202322:04EDGAR2Form 8-K - Current report
06/7/202322:01PRNUSFDA Removes Partial Clinical Hold on TakeAim Leukemia Study..
06/7/202322:00PRNUSCuris Announces $15.1 Million Registered Direct Offering
05/5/202321:30PRNUSCuris Reports Inducement Grants Under NASDAQ Listing Rule..
05/5/202306:01PRNUSCuris Provides First Quarter 2023 Business Update

Your Recent History

Delayed Upgrade Clock